Functional and Structural Insights into the Human PPARa/d/? Targeting Preferences of Anti-NASH Investigational Drugs, Lanifibranor, Seladelpar, and Elafibranor

Kamata, S; Honda, A; Ishikawa, R; Akahane, M; Fujita, A; Kaneko, C; Miyawaki, S; Habu, Y; Shiiyama, Y; Uchii, K; Machida, Y; Oyama, T; Ishii, I

Ishii, I (通讯作者)，Showa Pharmaceut Univ, Dept Hlth Chem, Machida, Tokyo 1948543, Japan.

ANTIOXIDANTS, 2023; 12 (8):

Abstract

No therapeutic drugs are currently available for nonalcoholic steatohepatitis (NASH) that progresses from nonalcoholic fatty liver via oxidative stres......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索